Status:
COMPLETED
Neopep-S-based EasyDew MD Regen Cream for Radiotherapy Subject After Breast Tumor Resection
Lead Sponsor:
Eun-ji Kim
Conditions:
Skin Lesion
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
This clinical study is conducted prospectively for 3 months after medical device treatment. It is a comparative clinical study of the leading control group.
Detailed Description
Subject is a patient who has a tumor removed from the breast and is receiving radiotherapy at the lesion. Subjects (and/or legal representatives) have agreed in writing to participate in the clinical...
Eligibility Criteria
Inclusion
- adults over the age of 19
- The tumor in the breast area is resected and radiotherapy is planned, performed, or Subjects with a history of irradiation
- Decide to participate in this clinical study arbitrarily and in the written informed consent a person to whom
Exclusion
- When participating in a clinical study, the findings of radiation dermatitis in the area are shown
- A person who shows signs of acute or chronic dermatological diseases
- In situations where the requirements of a clinical study cannot be complied with
- When the researcher's judgment determines that the participation of the study is inappropriate (e.g. Kelloid personality)
Key Trial Info
Start Date :
November 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 28 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06025058
Start Date
November 11 2022
End Date
July 28 2023
Last Update
September 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ajou University Hospital
Gyeonggi-do, South Korea